Share Price and Basic Stock Data
Last Updated: January 17, 2026, 6:53 am
| PEG Ratio | 13.52 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Galaxy Surfactants Ltd, operating in the oil drilling and exploration sector, reported a current market price of ₹1,883 and a market capitalization of ₹6,676 Cr. The company has experienced significant revenue growth over the years, with sales increasing from ₹3,684 Cr in FY 2022 to ₹4,462 Cr in FY 2023. For the trailing twelve months (TTM), sales stood at ₹4,791 Cr. Quarterly sales have shown fluctuations; for instance, sales were ₹1,232 Cr in September 2022 but dipped to ₹980 Cr in March 2023 before recovering to ₹983 Cr in September 2023. This inconsistent sales pattern suggests a response to market conditions and operational challenges. Despite these fluctuations, the overall trend indicates a robust growth trajectory compared to historical figures. The company’s ability to navigate market dynamics will be critical for sustaining revenue growth in the competitive landscape of oil drilling and exploration.
Profitability and Efficiency Metrics
Galaxy Surfactants exhibited varied profitability metrics, with a reported net profit of ₹286 Cr and a profit margin of 7.21% for FY 2025. The operating profit margin (OPM) has seen a decline, recorded at 12.07% for FY 2025, down from 13.00% in FY 2023, indicating challenges in maintaining profitability amid rising costs. The interest coverage ratio stood at a strong 26.50x, reflecting the company’s ability to meet its interest obligations comfortably. However, the return on equity (ROE) declined to 12.90% in FY 2025 from 20.23% in FY 2023, raising concerns about shareholder returns. The cash conversion cycle (CCC) averaged 73 days, consistent with industry norms but suggesting potential areas for operational improvement. Overall, while Galaxy Surfactants maintains a solid profitability baseline, its declining ROE and OPM signal a need for strategic adjustments to bolster profit margins and enhance shareholder value.
Balance Sheet Strength and Financial Ratios
Galaxy Surfactants’ balance sheet reflects a stable financial position, with total assets amounting to ₹3,450 Cr and total liabilities at ₹3,778 Cr as of FY 2025. The company has minimal borrowings, recorded at ₹268 Cr, resulting in a low long-term debt-to-equity ratio of 0.01, indicating a conservative leverage strategy. Reserves have increased to ₹2,499 Cr, enhancing the company’s financial flexibility. The current ratio stood at 2.14, well above the typical industry threshold of 1.5, suggesting strong liquidity. However, the price-to-book value ratio was at 3.08x, indicating that the stock may be overvalued relative to its book value. The inventory turnover ratio improved to 6.60, showcasing effective inventory management. Overall, while the balance sheet is robust, the high price-to-book ratio may warrant caution among potential investors.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Galaxy Surfactants indicates strong promoter confidence, with promoters holding 70.92% of the shares. This significant stake reflects a commitment to the company’s long-term vision. Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) hold 4.21% and 12.90%, respectively, indicating moderate institutional interest. However, the public shareholding has decreased to 11.96%, suggesting a potential consolidation of shares among institutional and promoter entities. The total number of shareholders has declined to 49,547, highlighting a possible reduction in retail investor participation. This concentrated shareholding could be a double-edged sword; while it may stabilize the stock, it could also limit liquidity and market participation from smaller investors. Investor confidence appears stable, but the declining public shareholding could raise questions about market accessibility.
Outlook, Risks, and Final Insight
Galaxy Surfactants faces a mixed outlook influenced by its operational performance and market conditions. The company’s strengths include a solid market position, strong liquidity, and low leverage, which provide a buffer against economic fluctuations. However, risks include declining profit margins, fluctuating sales, and a high price-to-book ratio, which could impact investor sentiment. To enhance its competitive edge, Galaxy Surfactants must focus on improving operational efficiency and addressing profitability challenges. Potential growth opportunities exist in expanding market share and optimizing production processes. Should the company manage to stabilize its profit margins and capitalize on growth opportunities, it may enhance shareholder value. Conversely, failure to address these challenges could hinder its growth trajectory and impact overall market perception. The strategic focus on operational improvements and market expansion will be crucial for navigating the upcoming fiscal periods.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Natural Resources Ltd | 1,313 Cr. | 102 | 110/16.6 | 826 | 14.1 | 0.00 % | 0.56 % | 2.87 % | 10.0 |
| Dolphin Offshore Enterprises (India) Ltd | 1,827 Cr. | 457 | 537/200 | 34.5 | 75.5 | 0.00 % | 14.7 % | 18.7 % | 1.00 |
| Deep Energy Resources Ltd | 999 Cr. | 312 | / | 694 | 121 | 0.00 % | 0.39 % | 0.35 % | 10.0 |
| Selan Explorations Technology Ltd | 881 Cr. | 580 | 969/475 | 13.4 | 309 | 0.00 % | 22.8 % | 17.2 % | 10.0 |
| Oil India Ltd | 72,978 Cr. | 449 | 492/322 | 12.2 | 346 | 2.56 % | 12.9 % | 13.3 % | 10.0 |
| Industry Average | 33,484.50 Cr | 410.29 | 154.89 | 600.59 | 1.03% | 10.56% | 9.87% | 6.85 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,232 | 1,085 | 980 | 942 | 983 | 940 | 929 | 974 | 1,063 | 1,042 | 1,145 | 1,278 | 1,326 |
| Expenses | 1,100 | 931 | 845 | 819 | 858 | 828 | 827 | 850 | 935 | 936 | 1,018 | 1,154 | 1,216 |
| Operating Profit | 132 | 154 | 135 | 123 | 125 | 112 | 102 | 124 | 128 | 106 | 127 | 124 | 110 |
| OPM % | 11% | 14% | 14% | 13% | 13% | 12% | 11% | 13% | 12% | 10% | 11% | 10% | 8% |
| Other Income | 1 | 4 | 7 | 2 | 3 | 6 | 24 | 5 | 9 | 4 | 8 | 11 | 6 |
| Interest | 6 | 6 | 6 | 6 | 5 | 6 | 5 | 4 | 4 | 5 | 6 | 7 | 7 |
| Depreciation | 20 | 22 | 23 | 24 | 25 | 25 | 26 | 27 | 28 | 28 | 28 | 29 | 30 |
| Profit before tax | 107 | 131 | 113 | 96 | 98 | 88 | 94 | 99 | 104 | 77 | 100 | 99 | 79 |
| Tax % | 21% | 19% | 20% | 22% | 21% | 19% | 18% | 19% | 19% | 16% | 24% | 20% | 16% |
| Net Profit | 84 | 106 | 91 | 75 | 77 | 71 | 78 | 80 | 85 | 65 | 76 | 79 | 66 |
| EPS in Rs | 23.66 | 29.96 | 25.53 | 21.20 | 21.84 | 20.13 | 21.86 | 22.48 | 23.89 | 18.22 | 21.40 | 22.42 | 18.75 |
Last Updated: January 12, 2026, 9:16 am
Below is a detailed analysis of the quarterly data for Galaxy Surfactants Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 1,326.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,278.00 Cr. (Jun 2025) to 1,326.00 Cr., marking an increase of 48.00 Cr..
- For Expenses, as of Sep 2025, the value is 1,216.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,154.00 Cr. (Jun 2025) to 1,216.00 Cr., marking an increase of 62.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 110.00 Cr.. The value appears to be declining and may need further review. It has decreased from 124.00 Cr. (Jun 2025) to 110.00 Cr., marking a decrease of 14.00 Cr..
- For OPM %, as of Sep 2025, the value is 8.00%. The value appears to be declining and may need further review. It has decreased from 10.00% (Jun 2025) to 8.00%, marking a decrease of 2.00%.
- For Other Income, as of Sep 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 11.00 Cr. (Jun 2025) to 6.00 Cr., marking a decrease of 5.00 Cr..
- For Interest, as of Sep 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 7.00 Cr..
- For Depreciation, as of Sep 2025, the value is 30.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 29.00 Cr. (Jun 2025) to 30.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 79.00 Cr.. The value appears to be declining and may need further review. It has decreased from 99.00 Cr. (Jun 2025) to 79.00 Cr., marking a decrease of 20.00 Cr..
- For Tax %, as of Sep 2025, the value is 16.00%. The value appears to be improving (decreasing) as expected. It has decreased from 20.00% (Jun 2025) to 16.00%, marking a decrease of 4.00%.
- For Net Profit, as of Sep 2025, the value is 66.00 Cr.. The value appears to be declining and may need further review. It has decreased from 79.00 Cr. (Jun 2025) to 66.00 Cr., marking a decrease of 13.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 18.75. The value appears to be declining and may need further review. It has decreased from 22.42 (Jun 2025) to 18.75, marking a decrease of 3.67.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:21 am
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,870 | 1,799 | 2,158 | 2,432 | 2,761 | 2,595 | 2,782 | 3,684 | 4,462 | 3,792 | 4,221 | 4,791 |
| Expenses | 1,681 | 1,563 | 1,886 | 2,144 | 2,408 | 2,226 | 2,334 | 3,284 | 3,894 | 3,330 | 3,737 | 4,324 |
| Operating Profit | 190 | 236 | 271 | 288 | 353 | 369 | 449 | 401 | 568 | 462 | 484 | 467 |
| OPM % | 10% | 13% | 13% | 12% | 13% | 14% | 16% | 11% | 13% | 12% | 11% | 10% |
| Other Income | 2 | 6 | 10 | 10 | 5 | 6 | 11 | 13 | 10 | 35 | 26 | 29 |
| Interest | 34 | 34 | 27 | 31 | 30 | 24 | 13 | 13 | 22 | 22 | 19 | 25 |
| Depreciation | 45 | 45 | 47 | 49 | 51 | 62 | 74 | 71 | 83 | 100 | 110 | 115 |
| Profit before tax | 112 | 163 | 207 | 219 | 277 | 289 | 372 | 329 | 473 | 375 | 380 | 355 |
| Tax % | 40% | 37% | 29% | 28% | 31% | 20% | 19% | 20% | 19% | 20% | 20% | |
| Net Profit | 67 | 103 | 148 | 158 | 191 | 230 | 302 | 263 | 381 | 301 | 305 | 286 |
| EPS in Rs | 19.03 | 28.97 | 41.64 | 44.57 | 53.87 | 64.99 | 85.22 | 74.12 | 107.46 | 85.03 | 86.00 | 80.79 |
| Dividend Payout % | 21% | 31% | 14% | 16% | 15% | 22% | 21% | 24% | 20% | 26% | 5% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 53.73% | 43.69% | 6.76% | 20.89% | 20.42% | 31.30% | -12.91% | 44.87% | -21.00% | 1.33% |
| Change in YoY Net Profit Growth (%) | 0.00% | -10.04% | -36.93% | 14.13% | -0.47% | 10.89% | -44.22% | 57.78% | -65.86% | 22.33% |
Galaxy Surfactants Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 10% |
| 3 Years: | 5% |
| TTM: | 18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 6% |
| 3 Years: | 5% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 6% |
| 3 Years: | -10% |
| 1 Year: | -19% |
| Return on Equity | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 18% |
| 3 Years: | 16% |
| Last Year: | 13% |
Last Updated: September 5, 2025, 4:25 am
Balance Sheet
Last Updated: December 4, 2025, 1:15 am
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 |
| Reserves | 342 | 412 | 539 | 683 | 841 | 1,032 | 1,266 | 1,539 | 1,847 | 2,144 | 2,327 | 2,499 |
| Borrowings | 451 | 412 | 393 | 348 | 298 | 396 | 289 | 421 | 327 | 187 | 210 | 268 |
| Other Liabilities | 231 | 250 | 315 | 385 | 389 | 348 | 458 | 602 | 518 | 539 | 877 | 975 |
| Total Liabilities | 1,060 | 1,109 | 1,283 | 1,452 | 1,563 | 1,812 | 2,049 | 2,597 | 2,728 | 2,906 | 3,450 | 3,778 |
| Fixed Assets | 459 | 436 | 456 | 447 | 519 | 748 | 712 | 760 | 923 | 973 | 1,030 | 1,029 |
| CWIP | 7 | 51 | 10 | 25 | 83 | 66 | 124 | 205 | 139 | 158 | 262 | 290 |
| Investments | 0 | 0 | 0 | 0 | 0 | 6 | 43 | 0 | 0 | 198 | 299 | 385 |
| Other Assets | 594 | 623 | 817 | 980 | 962 | 992 | 1,170 | 1,630 | 1,665 | 1,576 | 1,859 | 2,074 |
| Total Assets | 1,060 | 1,109 | 1,283 | 1,452 | 1,563 | 1,812 | 2,049 | 2,597 | 2,728 | 2,906 | 3,450 | 3,778 |
Below is a detailed analysis of the balance sheet data for Galaxy Surfactants Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 35.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 35.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,499.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,327.00 Cr. (Mar 2025) to 2,499.00 Cr., marking an increase of 172.00 Cr..
- For Borrowings, as of Sep 2025, the value is 268.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 210.00 Cr. (Mar 2025) to 268.00 Cr., marking an increase of 58.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 975.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 877.00 Cr. (Mar 2025) to 975.00 Cr., marking an increase of 98.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 3,778.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,450.00 Cr. (Mar 2025) to 3,778.00 Cr., marking an increase of 328.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,029.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,030.00 Cr. (Mar 2025) to 1,029.00 Cr., marking a decrease of 1.00 Cr..
- For CWIP, as of Sep 2025, the value is 290.00 Cr.. The value appears strong and on an upward trend. It has increased from 262.00 Cr. (Mar 2025) to 290.00 Cr., marking an increase of 28.00 Cr..
- For Investments, as of Sep 2025, the value is 385.00 Cr.. The value appears strong and on an upward trend. It has increased from 299.00 Cr. (Mar 2025) to 385.00 Cr., marking an increase of 86.00 Cr..
- For Other Assets, as of Sep 2025, the value is 2,074.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,859.00 Cr. (Mar 2025) to 2,074.00 Cr., marking an increase of 215.00 Cr..
- For Total Assets, as of Sep 2025, the value is 3,778.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,450.00 Cr. (Mar 2025) to 3,778.00 Cr., marking an increase of 328.00 Cr..
Notably, the Reserves (2,499.00 Cr.) exceed the Borrowings (268.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -261.00 | -176.00 | -122.00 | -60.00 | 55.00 | -27.00 | 160.00 | -20.00 | 241.00 | 275.00 | 274.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 43 | 51 | 59 | 63 | 56 | 62 | 62 | 63 | 50 | 57 | 59 |
| Inventory Days | 68 | 72 | 79 | 75 | 68 | 72 | 91 | 103 | 78 | 82 | 95 |
| Days Payable | 50 | 59 | 63 | 71 | 59 | 60 | 80 | 75 | 52 | 66 | 81 |
| Cash Conversion Cycle | 61 | 64 | 75 | 67 | 65 | 73 | 72 | 91 | 76 | 73 | 73 |
| Working Capital Days | 4 | 27 | 31 | 39 | 41 | 43 | 50 | 63 | 55 | 64 | 52 |
| ROCE % | 23% | 26% | 25% | 28% | 24% | 25% | 19% | 24% | 17% | 16% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Contra Fund | 51,993,788 | 1.84 | 915.56 | 41,173,788 | 2025-12-08 04:54:22 | 26.28% |
| SBI Balanced Advantage Fund | 46,405,618 | 2.08 | 817.16 | 53,293,368 | 2025-12-08 04:54:22 | -12.92% |
| HDFC Balanced Advantage Fund | 34,000,000 | 0.55 | 598.71 | N/A | N/A | N/A |
| SBI Large Cap Fund | 29,000,000 | 0.92 | 510.66 | N/A | N/A | N/A |
| SBI ELSS Tax Saver Fund | 26,493,555 | 1.44 | 466.53 | N/A | N/A | N/A |
| SBI PSU Fund | 25,750,000 | 7.87 | 453.43 | N/A | N/A | N/A |
| Aditya Birla Sun Life PSU Equity Fund | 18,291,648 | 5.72 | 322.1 | N/A | N/A | N/A |
| Kotak Large & Midcap Fund | 16,500,000 | 0.97 | 290.55 | 20,000,000 | 2025-12-15 00:55:52 | -17.5% |
| Kotak Flexicap Fund | 15,500,000 | 0.48 | 272.94 | 17,000,000 | 2025-12-15 00:55:52 | -8.82% |
| Kotak Multicap Fund | 15,500,000 | 1.22 | 272.94 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 86.00 | 85.03 | 107.46 | 74.12 | 85.22 |
| Diluted EPS (Rs.) | 86.00 | 85.03 | 107.46 | 74.12 | 85.22 |
| Cash EPS (Rs.) | 117.14 | 113.20 | 131.02 | 94.17 | 106.09 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 666.44 | 614.74 | 531.04 | 444.10 | 367.11 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 666.44 | 614.74 | 531.04 | 444.10 | 367.11 |
| Revenue From Operations / Share (Rs.) | 1191.44 | 1070.35 | 1253.95 | 1039.69 | 785.35 |
| PBDIT / Share (Rs.) | 143.88 | 140.39 | 163.08 | 116.56 | 129.67 |
| PBIT / Share (Rs.) | 112.75 | 112.23 | 139.53 | 96.52 | 108.81 |
| PBT / Share (Rs.) | 107.32 | 105.92 | 133.41 | 92.89 | 105.03 |
| Net Profit / Share (Rs.) | 86.01 | 85.04 | 107.47 | 74.13 | 85.23 |
| NP After MI And SOA / Share (Rs.) | 86.01 | 85.04 | 107.47 | 74.13 | 85.23 |
| PBDIT Margin (%) | 12.07 | 13.11 | 13.00 | 11.21 | 16.51 |
| PBIT Margin (%) | 9.46 | 10.48 | 11.12 | 9.28 | 13.85 |
| PBT Margin (%) | 9.00 | 9.89 | 10.63 | 8.93 | 13.37 |
| Net Profit Margin (%) | 7.21 | 7.94 | 8.57 | 7.12 | 10.85 |
| NP After MI And SOA Margin (%) | 7.21 | 7.94 | 8.57 | 7.12 | 10.85 |
| Return on Networth / Equity (%) | 12.90 | 13.83 | 20.23 | 16.69 | 23.21 |
| Return on Capital Employeed (%) | 16.09 | 17.21 | 24.07 | 19.71 | 26.98 |
| Return On Assets (%) | 8.80 | 10.34 | 13.93 | 10.10 | 14.74 |
| Long Term Debt / Equity (X) | 0.01 | 0.02 | 0.04 | 0.05 | 0.05 |
| Total Debt / Equity (X) | 0.06 | 0.06 | 0.14 | 0.23 | 0.18 |
| Asset Turnover Ratio (%) | 1.32 | 1.34 | 1.42 | 1.34 | 1.09 |
| Current Ratio (X) | 2.14 | 2.82 | 2.36 | 1.81 | 1.87 |
| Quick Ratio (X) | 1.40 | 1.90 | 1.41 | 0.99 | 1.18 |
| Inventory Turnover Ratio (X) | 6.60 | 4.15 | 4.30 | 4.78 | 4.19 |
| Dividend Payout Ratio (NP) (%) | 20.93 | 4.70 | 33.50 | 5.39 | 16.42 |
| Dividend Payout Ratio (CP) (%) | 15.36 | 3.53 | 27.48 | 4.24 | 13.19 |
| Earning Retention Ratio (%) | 79.07 | 95.30 | 66.50 | 94.61 | 83.58 |
| Cash Earning Retention Ratio (%) | 84.64 | 96.47 | 72.52 | 95.76 | 86.81 |
| Interest Coverage Ratio (X) | 26.50 | 22.22 | 26.64 | 32.16 | 34.25 |
| Interest Coverage Ratio (Post Tax) (X) | 16.84 | 14.46 | 18.56 | 21.45 | 23.51 |
| Enterprise Value (Cr.) | 7197.68 | 7937.75 | 8295.42 | 10453.78 | 9184.23 |
| EV / Net Operating Revenue (X) | 1.70 | 2.09 | 1.87 | 2.84 | 3.30 |
| EV / EBITDA (X) | 14.11 | 15.95 | 14.35 | 25.30 | 19.98 |
| MarketCap / Net Operating Revenue (X) | 1.72 | 2.12 | 1.86 | 2.76 | 3.25 |
| Retention Ratios (%) | 79.06 | 95.29 | 66.49 | 94.60 | 83.57 |
| Price / BV (X) | 3.08 | 3.69 | 4.39 | 6.45 | 6.96 |
| Price / Net Operating Revenue (X) | 1.72 | 2.12 | 1.86 | 2.76 | 3.25 |
| EarningsYield | 0.04 | 0.03 | 0.04 | 0.02 | 0.03 |
After reviewing the key financial ratios for Galaxy Surfactants Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 86.00. This value is within the healthy range. It has increased from 85.03 (Mar 24) to 86.00, marking an increase of 0.97.
- For Diluted EPS (Rs.), as of Mar 25, the value is 86.00. This value is within the healthy range. It has increased from 85.03 (Mar 24) to 86.00, marking an increase of 0.97.
- For Cash EPS (Rs.), as of Mar 25, the value is 117.14. This value is within the healthy range. It has increased from 113.20 (Mar 24) to 117.14, marking an increase of 3.94.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 666.44. It has increased from 614.74 (Mar 24) to 666.44, marking an increase of 51.70.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 666.44. It has increased from 614.74 (Mar 24) to 666.44, marking an increase of 51.70.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,191.44. It has increased from 1,070.35 (Mar 24) to 1,191.44, marking an increase of 121.09.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 143.88. This value is within the healthy range. It has increased from 140.39 (Mar 24) to 143.88, marking an increase of 3.49.
- For PBIT / Share (Rs.), as of Mar 25, the value is 112.75. This value is within the healthy range. It has increased from 112.23 (Mar 24) to 112.75, marking an increase of 0.52.
- For PBT / Share (Rs.), as of Mar 25, the value is 107.32. This value is within the healthy range. It has increased from 105.92 (Mar 24) to 107.32, marking an increase of 1.40.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 86.01. This value is within the healthy range. It has increased from 85.04 (Mar 24) to 86.01, marking an increase of 0.97.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 86.01. This value is within the healthy range. It has increased from 85.04 (Mar 24) to 86.01, marking an increase of 0.97.
- For PBDIT Margin (%), as of Mar 25, the value is 12.07. This value is within the healthy range. It has decreased from 13.11 (Mar 24) to 12.07, marking a decrease of 1.04.
- For PBIT Margin (%), as of Mar 25, the value is 9.46. This value is below the healthy minimum of 10. It has decreased from 10.48 (Mar 24) to 9.46, marking a decrease of 1.02.
- For PBT Margin (%), as of Mar 25, the value is 9.00. This value is below the healthy minimum of 10. It has decreased from 9.89 (Mar 24) to 9.00, marking a decrease of 0.89.
- For Net Profit Margin (%), as of Mar 25, the value is 7.21. This value is within the healthy range. It has decreased from 7.94 (Mar 24) to 7.21, marking a decrease of 0.73.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 7.21. This value is below the healthy minimum of 8. It has decreased from 7.94 (Mar 24) to 7.21, marking a decrease of 0.73.
- For Return on Networth / Equity (%), as of Mar 25, the value is 12.90. This value is below the healthy minimum of 15. It has decreased from 13.83 (Mar 24) to 12.90, marking a decrease of 0.93.
- For Return on Capital Employeed (%), as of Mar 25, the value is 16.09. This value is within the healthy range. It has decreased from 17.21 (Mar 24) to 16.09, marking a decrease of 1.12.
- For Return On Assets (%), as of Mar 25, the value is 8.80. This value is within the healthy range. It has decreased from 10.34 (Mar 24) to 8.80, marking a decrease of 1.54.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.06. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.06.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.32. It has decreased from 1.34 (Mar 24) to 1.32, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 2.14. This value is within the healthy range. It has decreased from 2.82 (Mar 24) to 2.14, marking a decrease of 0.68.
- For Quick Ratio (X), as of Mar 25, the value is 1.40. This value is within the healthy range. It has decreased from 1.90 (Mar 24) to 1.40, marking a decrease of 0.50.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.60. This value is within the healthy range. It has increased from 4.15 (Mar 24) to 6.60, marking an increase of 2.45.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 20.93. This value is within the healthy range. It has increased from 4.70 (Mar 24) to 20.93, marking an increase of 16.23.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 15.36. This value is below the healthy minimum of 20. It has increased from 3.53 (Mar 24) to 15.36, marking an increase of 11.83.
- For Earning Retention Ratio (%), as of Mar 25, the value is 79.07. This value exceeds the healthy maximum of 70. It has decreased from 95.30 (Mar 24) to 79.07, marking a decrease of 16.23.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 84.64. This value exceeds the healthy maximum of 70. It has decreased from 96.47 (Mar 24) to 84.64, marking a decrease of 11.83.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 26.50. This value is within the healthy range. It has increased from 22.22 (Mar 24) to 26.50, marking an increase of 4.28.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 16.84. This value is within the healthy range. It has increased from 14.46 (Mar 24) to 16.84, marking an increase of 2.38.
- For Enterprise Value (Cr.), as of Mar 25, the value is 7,197.68. It has decreased from 7,937.75 (Mar 24) to 7,197.68, marking a decrease of 740.07.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.70. This value is within the healthy range. It has decreased from 2.09 (Mar 24) to 1.70, marking a decrease of 0.39.
- For EV / EBITDA (X), as of Mar 25, the value is 14.11. This value is within the healthy range. It has decreased from 15.95 (Mar 24) to 14.11, marking a decrease of 1.84.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.72. This value is within the healthy range. It has decreased from 2.12 (Mar 24) to 1.72, marking a decrease of 0.40.
- For Retention Ratios (%), as of Mar 25, the value is 79.06. This value exceeds the healthy maximum of 70. It has decreased from 95.29 (Mar 24) to 79.06, marking a decrease of 16.23.
- For Price / BV (X), as of Mar 25, the value is 3.08. This value exceeds the healthy maximum of 3. It has decreased from 3.69 (Mar 24) to 3.08, marking a decrease of 0.61.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.72. This value is within the healthy range. It has decreased from 2.12 (Mar 24) to 1.72, marking a decrease of 0.40.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Galaxy Surfactants Ltd:
- Net Profit Margin: 7.21%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 16.09% (Industry Average ROCE: 10.56%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 12.9% (Industry Average ROE: 9.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 16.84
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.4
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 23.5 (Industry average Stock P/E: 154.89)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.06
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.21%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Gas Transmission/Marketing | GAIL Bhawan 16, Bhikaiji Cama Place, New Delhi Delhi 110066 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sandeep Kumar Gupta | Chairman & Managing Director |
| Mr. Rakesh Kumar Jain | Director - Finance & CFO |
| Mr. Deepak Gupta | Director - Projects |
| Mr. Ayush Gupta | Director - Human Resources |
| Mr. Rajeev Kumar Singhal | Director - Business Development |
| Mr. Sanjay Kumar | Director - Marketing |
| Mr. Akhilesh Jain | Non Official Independent Director |
| Mr. Sanjay Kashyap | Non Official Independent Director |
| Mrs. Kangabam Inaocha Devi | Non Official Independent Director |
| Mr. Yajurvendra Anil Mahajan | Non Official Independent Director |
| Ms. Kamini Chauhan Ratan | Government Nominee Director |
| Mr. Kushagra Mittal | Government Nominee Director |
FAQ
What is the intrinsic value of Galaxy Surfactants Ltd?
Galaxy Surfactants Ltd's intrinsic value (as of 18 January 2026) is ₹1867.63 which is 1.70% lower the current market price of ₹1,900.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹6,736 Cr. market cap, FY2025-2026 high/low of ₹2,750/1,860, reserves of ₹2,499 Cr, and liabilities of ₹3,778 Cr.
What is the Market Cap of Galaxy Surfactants Ltd?
The Market Cap of Galaxy Surfactants Ltd is 6,736 Cr..
What is the current Stock Price of Galaxy Surfactants Ltd as on 18 January 2026?
The current stock price of Galaxy Surfactants Ltd as on 18 January 2026 is ₹1,900.
What is the High / Low of Galaxy Surfactants Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Galaxy Surfactants Ltd stocks is ₹2,750/1,860.
What is the Stock P/E of Galaxy Surfactants Ltd?
The Stock P/E of Galaxy Surfactants Ltd is 23.5.
What is the Book Value of Galaxy Surfactants Ltd?
The Book Value of Galaxy Surfactants Ltd is 715.
What is the Dividend Yield of Galaxy Surfactants Ltd?
The Dividend Yield of Galaxy Surfactants Ltd is 1.16 %.
What is the ROCE of Galaxy Surfactants Ltd?
The ROCE of Galaxy Surfactants Ltd is 16.2 %.
What is the ROE of Galaxy Surfactants Ltd?
The ROE of Galaxy Surfactants Ltd is 13.5 %.
What is the Face Value of Galaxy Surfactants Ltd?
The Face Value of Galaxy Surfactants Ltd is 10.0.